Abemaciclib metabolite M18 (LSN3106729)，Abemaciclib 的代谢物， 是一种具有抗肿瘤活性的CDK抑制剂。Abemaciclib metabolite M18 和 CRBN 配体可用于设计 PROTAC CDK4/6 降解剂。
| 生物活性 | Abemaciclib metabolite M18 (LSN3106729), the metabolite of Abemaciclib (HY-16297A), is aCDKinhibitor with antitumor activity. Abemaciclib metabolite M18 and a CRBN ligand have been used to designPROTACCDK4/6 degrader[1]. |
| IC50& Target[1] | |
| 分子量 | |
| Formula | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com
